Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 7/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9751717 | 0.79 | TSHR (0.57) | TSHRRAB9ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL11066067 | 0.78 | — | — | |
| SCHEMBL14436880 | 0.77 | TSHR (0.84) | TSHRRAB9ASMN1; SMN2NPC1MEN1 | |
| SCHEMBL6536779 | 0.75 | — | — | |
| SCHEMBL18205594 | 0.75 | — | — | |
| SCHEMBL12430457 | 0.74 | — | — | |
| SCHEMBL5115040 | 0.74 | — | — | |
| SCHEMBL10676113 | 0.74 | — | — | |
| SCHEMBL11572549 | 0.74 | — | — | |
| SCHEMBL5998335 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0100952-A1 | Substituted azolylallyl ketones and carbinols | BAYER AG (DE) | 1984-02-22 | — | — | EP | claimed |
| EP-1475370-B1 | OPTICALLY ACTIVE AZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUI CHEMICALS INC (JP) | 2009-08-05 | — | — | EP | disclosed |
| EP-1475370-B1 | OPTICALLY ACTIVE AZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUI CHEMICALS INC (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-7271185-B2 | Optically active azole derivative and process for producing the same | MITSUI CHEMICALS, INC. (JP) | 2007-09-18 | — | — | US | disclosed |
| EP-1475370-A4 | OPTICALLY ACTIVE AZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUI CHEMICALS INC (JP) | 2005-07-13 | — | — | EP | disclosed |
| US-20050085521-A1 | Optically active azole derivative and process for producing the same | MITSUI CHEMICALS, INC. (JP) | 2005-04-21 | — | — | US | disclosed |
| EP-1475370-A1 | OPTICALLY ACTIVE AZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | Mitsui Chemicals, Inc. (JP) | 2004-11-10 | — | — | EP | disclosed |
| JP-2004131462-A | OPTICALLY ACTIVE AZOLE DERIVATIVE AND METHOD FOR PRODUCING THE SAME | MITSUI CHEMICALS INC | 2004-04-30 | — | — | JP | disclosed |
| WO-2003068758-A1 | OPTICALLY ACTIVE AZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | MITSUI CHEMICALS, INC. (JP) | 2003-08-21 | — | — | WO | disclosed |
| EP-0159586-B1 | AZOLYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND FUNGICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1988-11-30 | — | — | EP | disclosed |
| EP-0100952-A1 | Substituted azolylallyl ketones and carbinols | BAYER AG (DE) | 1984-02-22 | — | — | EP | disclosed |
| EP-0100952-A1 | Substituted azolylallyl ketones and carbinols | BAYER AG (DE) | 1984-02-22 | — | — | EP | disclosed |
| EP-0100952-A1 | Substituted azolylallyl ketones and carbinols | BAYER AG (DE) | 1984-02-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085521-A1 | Optically active azole derivative and process for producing the same | ADH1C, ADH1A, ADH5 | TSHR 4336/4885RAB9A 4405/4885SMN1; SMN2 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.